miércoles, 4 de agosto de 2010

Reconstitution of RPA-covered single-stranded DNA-activated ATR-Chk1 signaling


Reconstitution of RPA-covered single-stranded DNA-activated ATR-Chk1 signaling
Jun-Hyuk Choia, Laura A. Lindsey-Boltza, Michael Kempa, Aaron C. Masonb, Marc S. Woldb, and Aziz Sancara,1

+ Author Affiliations

aDepartment of Biochemistry and Biophysics, University of North Carolina School of Medicine, Chapel Hill, NC 27599; and
bDepartment of Biochemistry, Carver College of Medicine, University of Iowa, Iowa City, IA 52242
Contributed by Aziz Sancar, June 3, 2010 (sent for review May 12, 2010)

Abstract
ATR kinase is a critical upstream regulator of the checkpoint response to various forms of DNA damage. Previous studies have shown that ATR is recruited via its binding partner ATR-interacting protein (ATRIP) to replication protein A (RPA)-covered single-stranded DNA (RPA-ssDNA) generated at sites of DNA damage where ATR is then activated by TopBP1 to phosphorylate downstream targets including the Chk1 signal transducing kinase. However, this critical feature of the human ATR-initiated DNA damage checkpoint signaling has not been demonstrated in a defined system. Here we describe an in vitro checkpoint system in which RPA-ssDNA and TopBP1 are essential for phosphorylation of Chk1 by the purified ATR-ATRIP complex. Checkpoint defective RPA mutants fail to activate ATR kinase in this system, supporting the conclusion that this system is a faithful representation of the in vivo reaction. Interestingly, we find that an alternative form of RPA (aRPA), which does not support DNA replication, can substitute for the checkpoint function of RPA in vitro, thus revealing a potential role for aRPA in the activation of ATR kinase. We also find that TopBP1 is recruited to RPA-ssDNA in a manner dependent on ATRIP and that the N terminus of TopBP1 is required for efficient recruitment and activation of ATR kinase.

DNA damage checkpoint signal transduction topoisomerase IIβ binding protein 1
Footnotes
1To whom correspondence should be addressed. E-mail: aziz_sancar@med.unc.edu. Author contributions: J.-H.C., L.A.L.-B., and A.S. designed research; J.-H.C., L.A.L.-B., and M.K. performed research; A.C.M. and M.S.W. contributed new reagents/analytic tools; J.-H.C., L.A.L.-B., M.K., and A.S. analyzed data; and J.-H.C., L.A.L.-B., M.K., and A.S. wrote the paper.
The authors declare no conflict of interest.

See Commentary on page 13561.

This article contains supporting information online at
www.pnas.org/lookup/suppl/doi:10.1073/pnas.1007856107/-/DCSupplemental.

http://www.pnas.org/content/107/31/13660

No hay comentarios:

Publicar un comentario